App-Quantinova.ai

Eligibility for Ivabradine in Heart Failure: Representativeness of SHIFT in a Broad Population

Gianluigi Savarese - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

Ivabradine

Reduced Loop Diuretic Use in Patients Taking Sacubitril/Valsartan Compared With Enalapril: The Paradigm-HF Study

Brian Claggett - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with reduced ejection fraction

Sacubitril/valsartan

Outcomes of Pediatric Heart Failure Related Hospitalizations in Canada:2004-2013

Sunjidatul Islam - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ventricular septal defect

N/A

Linking Improved Processes of Care With Timeliness of Intravenous Diuresis for Acute Heart Failure

Caitlin Chang - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

furosemide GR

Initiation, Continuation, or Withdrawal of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction

Gregg C Fonawow - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with reduced ejection fraction

Angiotensin II

Is Thirst a Marker or Cause of Complicated Heart Failure Admissions?

D. Marshall Brinkley - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Advanced heart failure

Xylometazoline hydrochloride

A Disintegrin and Metalloproteinase 17 Deletion in Smooth Muscle Cell Transiently Suppresses Angiotensin II Mediated Hypertension

Jude Morton - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

Angiotensin II

Blood Pressure Homeostasis and Renal Function Depends on Normal c-myb Activity in Bone Marrow-Derived Cells

Andrew Levy - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Discharge Hospice Referral is Associated With Lower 30-Day All-Cause Readmission in Hospitalized Patients With Heart Failure: A Propensity-Matched Study of the Medicare-Linked OPTIMIZE-HF

Phillip H Lam - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Discharge Heart Rate and Outcomes in Hospitalized Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) and Stable Admission-to-Discharge Heart Failure

Phillip H Lam - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Reclassification and Hemodynamic Correlations of Patients With Diastolic Dysfunction Based on Updated Left Ventricular Diastolic Dysfunction Guidelines

Andrew D.M Grant - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular diastolic dysfunction

N/A

Automatic Quality Assessment of Echo Apical 4-chamber Images Using Computer Deep Learning

Amir Abdi - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Lower Discharge Systolic Blood Pressure (SBP) and Poor Outcomes among Hospitalized Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) and Stable Admission-to-Discharge SBP

Phillip H Lam - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

S-wave as a Sensitive Measurement of Left Ventricular Dysfunction in Pre-operative Aortic Insufficiency Evaluation

Francois Dagenais - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular dysfunction

N/A

Interest of Central Arterial Compliance in the Occurence of Discordant Grading in Aortic Stenosis

Lionel Tastet - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Aortic stenosis

N/A

Prognostic Value of Splenic Response Ratio in Rubidium-82 Positron Emission Tomography Myocardial Perfusion Imaging

Shrankhala Tewari - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

dipyridamole

Mortality Risk of Prolonged Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Bayesian Cross-Design Meta-Analysis of Completed and Prematurely Stopped Trials

Usman Baber - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Predictive Model for High-Risk Coronary Artery Disease: An Analysis From PROMISE

Sreekanth Vemulapalli - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Peripheral artery disease

N/A

The Impact of Dual Antiplatelet Therapy on Mortality: A Patient-Level Meta-Analysis

Gheorghe Doros - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

Clopidogrel bisulfate

Randomized Trial of Short vs Ultra Short Radial Artery Clamp Time Post Trans-radial Cardiac Catheterization

Andrew Yadegari - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hematoma

Heparin

Filters

28841 Abstracts